+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Serum Separation Gel Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 121 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 5012630

The Serum Separation Gel Market studied was anticipated to grow with a CAGR of 4.6% during the forecast period. The major factors attributing to the growth of the market are a rise in the number of blood tests and blood banks to examine state and type of blood. Rising prevalence of Bloodstream infections diseases like nosocomial candidemia has increased the demand for the products. For instance, as per the study report published by the National Center for Biotechnology in 2019, nosocomial candidemia is the most common bloodstream infection, associated with significant morbidity and mortality across the globe. Also, a rise in awareness among the public about infectious disease diagnosis is expected to result in a greater number of new examinations propelling the serum separation gel market.

Key Market Trends

Serum Separation Gel Integrated with Tubes are Expected to Hold the Major Market Share in the Serum Separation Gels Market

The serum separation gels integrated with the tube are is expected to dominate the industry over the forecast period. The lucrative growth of the segment can be attributed to a rise in the adoption of these tubes for clinical research purposes in pathological science to control the growing global burden of infectious disease. The huge demand for increased application of these tubes can be due to their enhanced convenience and sample handling. Also, due to their advantages such as higher resistance to irradiation, lower interference on clinical test results, and others are expected to boost the growth of the market.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the global serum separation gels market throughout the forecast period. This dominance is mainly owing to a steep rise in the incidence of hematological disorders and various infectious diseases in the region. Most of the cases were recorded among the elder population demanding the growth of the market in the region. As per the Centers for Disease Control and Prevention (CDC) report published in 2019, bloodstream infections are 4th most common cause of mortality among the people aged 60 or above. Thus, due to the presence of a huge number of baby boomers, the United States registers the highest market revenue. Also, the higher availability of favorable co-pay systems and an increased number of blood banks with advanced infrastructure boost market growth. Furthermore, a rising preference for digital healthcare services among the public to access personal health and fitness in the region contributes to its outstanding share in the growth of the global market.

Competitive Landscape

The global serum separation gels market is moderately competitive and consists of several major players. Some prominent players in the market are implementing various strategies such as launching new products with the rise in the serology research fundings and collaborations. While others are focusing on mergers & acquisitions to consolidate their market positions across the globe during the forecast period. Some of the companies which are currently dominating the market are Cardinal Health Inc, IntervacTechnology, Becton Dickinson & Company, Greiner Bio-One International GmbH, and Sekisui Diagnostics

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Global Prevalence of Infections and Rise in Geriatric Population
4.2.2 Increased Number of Contract Research Oragnisations in the Biotechnology Industry
4.3 Market Restraints
4.3.1 Highly Expensive Serum Separation Gel Tubes
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 Product Type
5.1.1 Serum Separation Gel Integrated with Tube
5.1.2 Serum Separation Gel without Tubes
5.2 End-Users
5.2.1 Hospital
5.2.2 Blood Bank
5.2.3 Pharmaceutical & Biotechnology Companies
5.2.4 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Cardinal Health, Inc.
6.1.2 InterVacTechnology OU
6.1.3 Becton Dickinson & Company
6.1.4 Greiner Bio One International GmbH
6.1.5 Sekisui Diagnostics, LLC
6.1.6 FL MEDICAL srl Unipersonale
6.1.7 BIOSIGMA S.r.l.
6.1.8 BioVision, Inc.
6.1.9 Bio-Rad Laboratories Inc.
6.1.10 Danaher Corporation

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cardinal Health, Inc.
  • InterVacTechnology OU
  • Becton Dickinson & Company
  • Greiner Bio One International GmbH
  • Sekisui Diagnostics, LLC
  • FL MEDICAL srl Unipersonale
  • BIOSIGMA S.r.l.
  • BioVision, Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation